APA

Apelgren L. D., Bailey D. L., Briggs S. L., Barton R. L., Guttman-Carlisle D., Koppel G. A., Nichols C. L., Scott W. L., Lindstrom T. D. & Baker A. L. (19950406). Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. : Bioconjugate chemistry.

Chicago

Apelgren L D, Bailey D L, Briggs S L, Barton R L, Guttman-Carlisle D, Koppel G A, Nichols C L, Scott W L, Lindstrom T D and Baker A L. 19950406. Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. : Bioconjugate chemistry.

Harvard

Apelgren L. D., Bailey D. L., Briggs S. L., Barton R. L., Guttman-Carlisle D., Koppel G. A., Nichols C. L., Scott W. L., Lindstrom T. D. and Baker A. L. (19950406). Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. : Bioconjugate chemistry.

MLA

Apelgren L D, Bailey D L, Briggs S L, Barton R L, Guttman-Carlisle D, Koppel G A, Nichols C L, Scott W L, Lindstrom T D and Baker A L. Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. : Bioconjugate chemistry. 19950406.